Whitehawk Therapeutics (WHWK) Assets Average (2018 - 2025)
Historic Assets Average for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $173.9 million.
- Whitehawk Therapeutics' Assets Average rose 8569.44% to $173.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.9 million, marking a year-over-year increase of 8569.44%. This contributed to the annual value of $101.4 million for FY2024, which is 3597.49% down from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Assets Average is $173.9 million, which was up 8569.44% from $207.4 million recorded in Q2 2025.
- Whitehawk Therapeutics' Assets Average's 5-year high stood at $207.4 million during Q2 2025, with a 5-year trough of $39.3 million in Q2 2021.
- In the last 5 years, Whitehawk Therapeutics' Assets Average had a median value of $145.4 million in 2023 and averaged $133.7 million.
- In the last 5 years, Whitehawk Therapeutics' Assets Average skyrocketed by 24479.05% in 2022 and then tumbled by 4265.81% in 2024.
- Whitehawk Therapeutics' Assets Average (Quarter) stood at $163.3 million in 2021, then increased by 15.81% to $189.2 million in 2022, then decreased by 28.09% to $136.0 million in 2023, then crashed by 42.66% to $78.0 million in 2024, then surged by 122.95% to $173.9 million in 2025.
- Its last three reported values are $173.9 million in Q3 2025, $207.4 million for Q2 2025, and $152.2 million during Q1 2025.